Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?
Open Access
- 30 November 2021
- journal article
- Published by Aboutscience Srl in Journal of Circulating Biomarkers
- Vol. 10, 20-25
- https://doi.org/10.33393/jcb.2021.2327
Abstract
Interleukin-33 (IL-33), a member of the IL-1 family, is critically involved in the modulation of the activity of a diverse range of immunocompetent cells. Essential roles have been implicated in cardioprotection, in both innate and adaptive immune responses in mucosal organs, and in the maintenance of adipose tissue cells. Over the past 10 years, several studies evaluated the usability of IL-33 as a biomarker in diseases of inflammatory and noninflammatory origin. Our group is currently evaluating the predictive role of serum IL-33 in acute kidney injury (AKI). The aim of the article is to discuss selected studies on IL-33 in different diseases and its potential role as a biomarker molecule.Keywords
This publication has 56 references indexed in Scilit:
- Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosisJournal of Neuroimmunology, 2012
- Elevated Levels of Interleukin-33 in the Nasal Secretions of Patients with Allergic RhinitisInternational Archives of Allergy and Immunology, 2012
- Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter StrainThe Journal of Immunology, 2012
- Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney DiseaseJournal of Clinical Immunology, 2011
- Interleukin 33 and ST2 in non–ST-elevation myocardial infarction: Comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNPAmerican Heart Journal, 2011
- Serum Interleukin-33 Levels in Patients with Gastric CancerDigestive Diseases and Sciences, 2011
- Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid ArthritisJournal of Korean Medical Science, 2011
- Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid ArthritisThe Journal of Rheumatology, 2010
- Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injuryTransplantation Reviews, 2010
- Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocketEMBO Reports, 2008